Ignite Creation Date:
2024-05-06 @ 5:09 PM
Last Modification Date:
2024-10-26 @ 2:23 PM
Study NCT ID:
NCT05212454
Status:
RECRUITING
Last Update Posted:
2023-04-25
First Post:
2022-01-15
Brief Title:
Efficacy of Supplement Adjuvant Capecitabine in HRHER2- Breast Cancer Patients With High Risks
Sponsor:
Second Affiliated Hospital School of Medicine Zhejiang University
Organization:
Second Affiliated Hospital School of Medicine Zhejiang University
Organization Data
Organization:
Second Affiliated Hospital School of Medicine Zhejiang University
Class:
OTHER
Study ID:
2021-1116
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Second Affiliated Hospital School of Medicine Zhejiang University
Lead Sponsor Class:
OTHER
Responsible Party:
Wei Tian
Responsible Party Title:
Vice Director of Department of Breast Surgery and Oncology
Responsible Party Type:
PRINCIPAL_INVESTIGATOR
Responsible Party Affiliation:
Second Affiliated Hospital School of Medicine Zhejiang University
Old Name:
None
Old Organization:
None